The global pain management therapeutics market is expected to exceed US$ 83 billion by 2024, registering a compound annual growth rate (CAGR) of more than 3.5% during the forecast period. The increase in the incidence of chronic pain disorders, rise in geriatric population with high risk of various diseases, growing adoption of pain management therapeutics among end users, and favorable regulatory scenario and health care reforms are driving the market. However, patent expiry of key drugs and entry of generics, prescription drug abuse, and long-term pain relief from surgical procedures, alternative therapies, and medical devices are hindering the growth of the market.
In this report, the global pain management therapeutics market is segmented by therapeutics, indication, and region. On the basis of therapeutics, the market is segmented into antidepressants, anesthetics, anticonvulsants, opioids, non-steroidal anti-inflammatory drugs, antimigraine agents, and other non-narcotic analgesic. The market by indication includes migraine, cancer pain, neuropathic pain, fibromyalgia, chronic back pain, arthritic pain, and post-operative pain.
The global pain management therapeutics market is segmentedon the basis of key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominated the global market in 2015 and is expected to lead the market during the forecast period. However, Asia Pacific is projected to register the highest CAGR during the forecast period. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional pain management therapeutics market and analyzes the variations in the growth of the industry in certain regions.
Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limitedare the most active players in the pain management therapeutics market.
A glimpse of the report structure is provided in the report description available on the website.
This report covers the pain management therapeutics market, in terms of value, and forecasts the market size till 2024. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
The deep-dive study on the pain management therapeutics market will help customers with the identification of new market opportunities and targeted promotional plans.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org